Maryland 2025 Regular Session

Maryland Senate Bill SB875

Introduced
2/3/25  

Caption

Public Health – Medetomidine and Xylazine Consumer Protection Act

Companion Bills

MD HB1109

Crossfiled Public Health - Medetomidine and Xylazine Consumer Protection Act

Previously Filed As

MD HB1229

Public Health - Kratom Consumer Protection Act

MD HB1230

Public Health - Tianeptine Consumer Protection Act

MD SB220

Public Health – Public Health Services and Protections – Revisions

MD HB42

Public Health - Public Health Services and Protections - Revisions

MD SB1

Electricity and Gas - Retail Supply - Regulation and Consumer Protection

MD HB267

Electricity and Gas - Retail Supply - Regulation and Consumer Protection

MD SB542

Public Safety - Emergency Management - Consumer Protections Against Price Gouging

MD SB844

Consumer Protection – Online Products and Services – Children’s Data

MD SB949

Consumer Protection - Self-Administered Sexual Assault Evidence Collection Kits

MD HB775

Public Safety - Emergency Management - Consumer Protections Against Price Gouging

Similar Bills

PA SB865

In miscellaneous provisions, further providing for urine drug screening requirement and providing for medetomidine awareness education.

MD HB1109

Public Health - Medetomidine and Xylazine Consumer Protection Act

NY A09001

Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.

NY A08979

Provides that no corporation, partnership, limited liability company, firm, online platform, or any other business entity doing business in this state shall knowingly sell, offer for sale, or deliver medetomidine to individuals without proof of its intended use for institutional, veterinary, or scientific purposes.

DE SJR9

Designating August 31, 2025, As "international Overdose Awareness Day" In The State Of Delaware And Requiring The State Flag To Be Flown At Half-staff In Observance.